Skip to content

Medical-device intelligence

Terumo Cardiovascular Systems Corporation: FDA clearances and recalls

Research Terumo Cardiovascular Systems Corporation in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

29 clearance records and 358 recall records in the covered releases, across 1 source company names and 26 product codes. Dated history runs from Sep 19, 2002 to May 28, 2025.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

387 matching records
Device / recordCompany in FDA recordSourceSource date
Perfusion System 8000, base 5 pump, 220V/240V safety monitor included The Sarns Modular Perfusion System 8000 is indicated for use for up to 6…Z-0129-2013 · DTQTerumo Cardiovascular Systems CorporationRecallOct 24, 2012FDA classification date
Perfusion System 8000, base 4 pump, 100V safety monitor included The Sarns Modular Perfusion System 8000 is indicated for use for up to 6 hour…Z-0130-2013 · DTQTerumo Cardiovascular Systems CorporationRecallOct 24, 2012FDA classification date
Perfusion System 8000, base 5 pump, 100V safety monitor included The Sarns Modular Perfusion System 8000 is indicated for use for up to 6 hour…Z-0131-2013 · DTQTerumo Cardiovascular Systems CorporationRecallOct 24, 2012FDA classification date
Terumo Backplate Replacement CXFVR 1500 Holder The Flexible venous Reservoir is mounted on the Backplate/Holder and secures the flexible reser…Z-0071-2013 · KRITerumo Cardiovascular Systems CorporationRecallOct 16, 2012FDA classification date
Battery, 100/115V (Includes charger and connecting cable) The Sarns" Centrifugal System is indicated for use in cardiopulmonary bypass procedu…Z-0049-2013 · KFMTerumo Cardiovascular Systems CorporationRecallOct 11, 2012FDA classification date
Battery, 220V (Includes charger and connecting cable) The Sarns" Centrifugal System is indicated for use in cardiopulmonary bypass procedures …Z-0050-2013 · KFMTerumo Cardiovascular Systems CorporationRecallOct 11, 2012FDA classification date
Sarns Centrifugal System Control module, 100/115V The Sarns Centrifugal System is indicated for use in cardiopulmonary bypass procedures only.Z-0051-2013 · KFMTerumo Cardiovascular Systems CorporationRecallOct 11, 2012FDA classification date
Sarns Centrifugal System Control module, 220/240V The Sarns Centrifugal System is indicated for use in cardiopulmonary bypass procedures only.Z-0052-2013 · KFMTerumo Cardiovascular Systems CorporationRecallOct 11, 2012FDA classification date
Sarns Centrifugal System Control module System 9000 The Sarns Centrifugal System is indicated for use in cardiopulmonary bypass procedures onl…Z-0053-2013 · KFMTerumo Cardiovascular Systems CorporationRecallOct 11, 2012FDA classification date
Terumo Advanced Perfusion System 1 Flow Module indicated for use in extracorporeal circulation of blood for arterial perfusion, regional perfu…Z-2449-2012 · DTQTerumo Cardiovascular Systems CorporationRecallSep 25, 2012FDA classification date
Terumo Advanced Perfusion System 1 ASSEMBLY FLOW POD Product Usage: The Terumo Advanced Perfusion System 1 is indicated for use in extracorpor…Z-2443-2012 · DTQTerumo Cardiovascular Systems CorporationRecallSep 24, 2012FDA classification date
Safety monitor included with System 8000 Base The Sarns" Modular Perfusion System 8000 is indicated for use for up to 6 hours on the extracorp…Z-2348-2012 · DTQTerumo Cardiovascular Systems CorporationRecallSep 11, 2012FDA classification date
Serial interface module RS-232 Product Usage: The System 1 provides perfusion case data transfer through the use of the data transfer module.…Z-2230-2012 · DTQTerumo Cardiovascular Systems CorporationRecallAug 21, 2012FDA classification date
Serial interface module RS-485 Product Usage: The System 1 provides perfusion case data transfer through the use of the data transfer module.…Z-2231-2012 · DTQTerumo Cardiovascular Systems CorporationRecallAug 21, 2012FDA classification date
Interface module for CDl System 100/101 Product Usage: The Interface Module for CDl 500 is the interface between the CDl 500 monitor and the …Z-2232-2012 · DTQTerumo Cardiovascular Systems CorporationRecallAug 21, 2012FDA classification date
Interface module for CDl System 500 Product Usage: The Interface Module for CDl 500 is the interface between the CDl 500 monitor and the syst…Z-2233-2012 · DTQTerumo Cardiovascular Systems CorporationRecallAug 21, 2012FDA classification date
System 8000 Base Product Usage: The Sarns Modular Perfusion System 8000 is indicated for use for up to 6 hours on the extracorporeal circulat…Z-2218-2012 · DTQTerumo Cardiovascular Systems CorporationRecallAug 16, 2012FDA classification date
System 1 base 100/120V The Terumo Advanced Perfusion System 1 is indicated for use in extracorporeal circulation of blood for arterial perfusi…Z-2177-2012 · DTQTerumo Cardiovascular Systems CorporationRecallAug 9, 2012FDA classification date
System 1 base 220/240V The Terumo Advanced Perfusion System 1 is indicated for use in extracorporeal circulation of blood for arterial perfusi…Z-2178-2012 · DTQTerumo Cardiovascular Systems CorporationRecallAug 9, 2012FDA classification date
System 1 Base 100/120V The Terumo Advanced Perfusion System 1 is indicated for use for up to 6 hours on the extracorporeal circulation of bloo…Z-2055-2012 · DTQTerumo Cardiovascular Systems CorporationRecallJul 20, 2012FDA classification date
System 1 Base 220/240V The Terumo Advanced Perfusion System 1 is indicated for use for up to 6 hours on the extracorporeal circulation of bloo…Z-2056-2012 · DTQTerumo Cardiovascular Systems CorporationRecallJul 20, 2012FDA classification date
Terumo Advanced Perfusion System 1. System 1 base 100/120V. The Terumo Advanced Perfusion System I is indicated for use in extracorporeal cir…Z-2042-2012 · DTQTerumo Cardiovascular Systems CorporationRecallJul 19, 2012FDA classification date
Terumo Advanced Perfusion System 1. System 1 base 220/240V. The Terumo Advanced Perfusion System I is indicated for use in extracorporeal cir…Z-2043-2012 · DTQTerumo Cardiovascular Systems CorporationRecallJul 19, 2012FDA classification date
Sarns Modular Perfusion System 8000 base, 4 pump 115V. The Sarns Modular Perfusion system 8000 is indicated for use for up to 6 hours on the e…Z-2044-2012 · DTQTerumo Cardiovascular Systems CorporationRecallJul 19, 2012FDA classification date
Sarns Modular Perfusion System 8000 base, 5 pump 115V. The Sarns Modular Perfusion Systern 8000 is indicated for use for up to 6 hours on the …Z-2045-2012 · DTQTerumo Cardiovascular Systems CorporationRecallJul 19, 2012FDA classification date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗